Klivira
Request demo

Streamlining Medicare Trelegy Prior Authorization Workflows

Navigating the complexities of Medicare Trelegy prior authorization is a significant challenge for revenue cycle and prior authorization teams. Klivira provides a robust solution to automate and accelerate this critical process.

Trelegy (fluticasone furoate/umeclidinium/vilanterol) is a frequently prescribed triple therapy for chronic obstructive pulmonary disease (COPD) and asthma. For Medicare beneficiaries, securing timely prior authorization for this high-volume medication requires precise navigation of distinct payer channels and policy requirements, particularly across Medicare Advantage and Part D plans. Klivira’s platform is engineered to address these specific operational demands, integrating directly into your existing EMR workflows.

Understanding Trelegy PA Across Medicare Segments

While Original Medicare (Part A and B) has a limited scope for prior authorization, Trelegy, as a prescription drug, falls under Medicare Part D. Part D plans are administered by private insurers and often require prior authorization based on CMS-approved formularies, step-therapy protocols, and medical necessity criteria. Medicare Advantage (Part C) plans, which often include prescription drug coverage, also impose their own prior authorization requirements, which can be extensive.

Navigating Medicare Part D and Advantage Plan PA for Trelegy

For Trelegy, prior authorization submissions primarily route through the specific Medicare Part D or Medicare Advantage plan. These plans utilize their own PBMs and policy libraries, which often include step-therapy requirements (e.g., trying a less expensive dual bronchodilator first) or specific diagnostic criteria for initial and continued authorization. Klivira's platform automates the identification of the correct plan and routes the request through the appropriate ePA channel, such as NCPDP SCRIPT, where available.

Policy Adherence: NCDs, LCDs, and Plan-Specific Criteria

Although Trelegy PA is largely driven by Part D and MA plan policies, National Coverage Determinations (NCDs) published by CMS and Local Coverage Determinations (LCDs) issued by Medicare Administrative Contractors (MACs) can inform coverage decisions. Klivira integrates these policy sources, ensuring submitted documentation aligns with the latest NCDs, relevant MAC-specific LCDs (from entities like Noridian, NGS, or Novitas), and the specific criteria of the patient's Part D or MA plan, minimizing the risk of denials due to incomplete or misaligned information.

Common Challenges in Medicare Trelegy PA

  • Distinguishing between Original Medicare, Medicare Advantage, and Part D requirements.
  • Adhering to plan-specific step-therapy protocols and formulary exceptions.
  • Ensuring comprehensive clinical documentation to support medical necessity.
  • Navigating varying submission channels (e.g., payer portals, fax, ePA) for different Part D and MA plans.
  • Managing the high volume of renewals for chronic respiratory conditions.

Klivira's Approach to Medicare Trelegy PA Automation

Klivira’s platform provides end-to-end automation for Medicare Trelegy prior authorization. For Part D and Medicare Advantage plans, our system dynamically identifies the correct payer and plan, retrieves specific formulary and PA criteria, and intelligently populates and submits authorization requests. This significantly reduces manual data entry, accelerates submission times, and helps ensure that necessary clinical documentation is included to meet payer-specific requirements, improving first-pass approval rates.

Frequently asked questions

Does Original Medicare require prior authorization for Trelegy?

Original Medicare (Part A and B) has a limited scope for prior authorization, primarily for certain medical services and durable medical equipment. Trelegy is a prescription drug, and its prior authorization requirements fall under Medicare Part D or Medicare Advantage plans, which are administered by private insurers.

How does Klivira handle different Medicare Part D plans for Trelegy PA?

Klivira's platform is designed to identify the specific Medicare Part D plan for each patient. It then accesses that plan's unique formulary and prior authorization criteria, including step-therapy rules, to ensure the request is tailored and submitted through the correct electronic or manual channel, streamlining the process regardless of the specific Part D insurer.

What documentation is typically needed for Trelegy prior authorization under Medicare?

Commonly required documentation for Trelegy PA under Medicare Part D or Medicare Advantage plans includes patient demographics, diagnosis (ICD-10 codes for COPD or asthma), previous medication trials (for step therapy), lung function test results (e.g., FEV1), and a physician's attestation of medical necessity. Klivira helps aggregate and attach this information from your EMR.

How does Klivira ensure compliance with CMS regulations for Trelegy PA?

Klivira continuously monitors and updates its system to align with CMS guidelines for prior authorization, particularly those affecting Medicare Advantage and Part D plans. While CMS-0057-F primarily impacts MA plans, our platform helps ensure that all submissions adhere to current regulatory frameworks and payer-specific policies, reducing compliance risk for your organization.

Can Klivira integrate with our EMR for Trelegy PA submissions?

Yes, Klivira specializes in deep EMR integration, utilizing standards like SMART on FHIR where applicable. This allows for seamless extraction of patient data, clinical notes, and medication histories directly from your EMR to populate prior authorization requests for Trelegy, minimizing manual data entry and improving accuracy.

Related coverage

Other trelegy prior authorization by payer

Other trelegy prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo